Advertisement

ADVERTISEMENT

Peripheral arterial disease

A Percutaneous Crossing Algorithm for Femoropopliteal and Tibial Artery Chronic Total Occlusions (PCTO Algorithm)
03/28/2019

Subhash Banerjee, MD1,2;  Mehdi H. Shishehbor, DO, MPH, PhD3;  Jihad A. Mustapha, MD4;  Ehrin J. Armstrong, MD, MSc5,6;  Mohammad Ansari, MD7;  John H. Rundback, MD8;  Bryan Fisher, MD9; Constantino S. Peña, MD10;  Emmanouil S. Brilakis, MD, PhD2,11;  Arthur C. Lee, MD12;  Sahil Parikh, MD13

Subhash Banerjee, MD1,2;  Mehdi H. Sh...
This review outlines a contemporary ultrasound-based approach to crossing femoropopliteal PCTOs based on a review of prospectively collected case report surveys, published evidence, and expert opinion compiled by the writing group members.
This review outlines a contemporary ultrasound-based approach to crossing femoropopliteal PCTOs based on a review of prospectively collected case report surveys, published evidence, and expert opinion compiled by the writing group members.
This review outlines a...
03/28/2019
Journal of Invasive Cardiology
Original Research
Single Access Versus Dual Antegrade and Retrograde Access Approach for Chronic Total Occlusion Recanalization in Complex Peripheral Arterial Disease
02/22/2019

Joji J. Varghese, MD1; Bailey Ann Estes, RN-C1; Brad J. Martinsen, PhD2; Zsuzsanna Igyarto, PhD2; Jihad A. Mustapha, MD3

 

1Hendrick Medical Center, Abilene, Texas; 2Cardiovascular Systems, Inc., St. Paul, Minnesota; 3Advanced Cardiac & Vascular Amputation Prevention Centers, Grand Rapids, Michigan

Joji J. Varghese, MD1; Bailey Ann Est...
In this study, researchers evaluated the efficacy and safety of initial dual antegrade and retrograde access approach compared with single antegrade or retrograde approach for crossing any level of CTO.
In this study, researchers evaluated the efficacy and safety of initial dual antegrade and retrograde access approach compared with single antegrade or retrograde approach for crossing any level of CTO.
In this study, researchers...
02/22/2019
Vascular Disease Management
Case Report
Late Presentation of a Symptomatic Iliac Artery Pseudoaneurysm
10/19/2018

Brian Roe, DO and Vincent Varghese, DO

 

Division of Interventional Cardiology and Endovascular Medicine, Deborah Heart and Lung Center, Browns Mills, New Jersey

Brian Roe, DO and Vincent Varghese, D...
A case report of an 80-year-old man with a history of right common iliac artery stent angioplasty and a subsequent iliac pseudoaneurysm formation.
A case report of an 80-year-old man with a history of right common iliac artery stent angioplasty and a subsequent iliac pseudoaneurysm formation.
A case report of an 80-year-old...
10/19/2018
Vascular Disease Management
Editor's Corner
Effectively Screening PAD Patients for CLI
09/13/2018

Craig Walker, MD

Cardiovascular Institute of the South, Houma, Louisiana

Craig Walker, MD Cardiovascular Inst...
Craig Walker, MD, provides comment on Dainis Krievins and colleagues' submission about the high prevalence of asymptomatic ischemia-producing coronary stenosis in patients with critical limb ischemia.
Craig Walker, MD, provides comment on Dainis Krievins and colleagues' submission about the high prevalence of asymptomatic ischemia-producing coronary stenosis in patients with critical limb ischemia.
Craig Walker, MD, provides...
09/13/2018
Vascular Disease Management
Original Research
A Multi-Center, Prospective, Post-Market Registry to Evaluate Procedural Outcomes Using the Cardiva Medical VASCADE Vascular Closure System (VCS)
09/13/2018

Craig Walker, MD1; Stefan Kiesz, MD2; Barry Bertolet, MD3; David Weatherford, MD4; Pradeep K. Nair, MD1; Mehdi H. Shishehbor, DO, MPH, PhD5

 

1Cardiovascular Institute of the South, Houma, Louisiana; 2San Antonio Endovascular and Heart Institute, San Antonio, Texas; 3Cardiology Associates of North Mississippi, Tupelo, Mississippi; 4Coastal Surgery Specialists, Coastal Surgery Specialists, Wilmington, North Carolina; 5University Hospitals Harrington Heart & Vascular Institute, Cleveland, Ohio

Craig Walker, MD1; Stefan Kiesz, MD2;...
A study led by Craig Walker, MD, confirms the safety and efficacy of the VASCADE VCS device when used in closure of antegrade femoral access sites during peripheral endovascular interventions in the treatment of PAD.
A study led by Craig Walker, MD, confirms the safety and efficacy of the VASCADE VCS device when used in closure of antegrade femoral access sites during peripheral endovascular interventions in the treatment of PAD.
A study led by Craig Walker, MD,...
09/13/2018
Vascular Disease Management
Conference Coverage
Fully Percutaneous Femoropopliteal Bypass: First-of-its-Kind Procedure for Patients With Peripheral Artery Disease
08/28/2018

Jihad Mustapha, MD

 

Advanced Cardiac & Vascular Amputation Prevention Centers Grand Rapids, Michigan

Jihad Mustapha, MD   Advanced Cardi...
Jihad Mustapha, MD, explains how percutaneous femoropopliteal bypass, a relatively new intervention, may be a potential solution for meeting unmet needs in patients with peripheral artery disease.
Jihad Mustapha, MD, explains how percutaneous femoropopliteal bypass, a relatively new intervention, may be a potential solution for meeting unmet needs in patients with peripheral artery disease.
Jihad Mustapha, MD, explains how...
08/28/2018
Vascular Disease Management
Original Research
Facilitated Intraluminal Guidewire Passage in Femoropopliteal Occlusive Pathology: Simplified Instrumentation Technique
07/16/2018

Frank Pomposelli, Jr, MD1; Albert K. Chin, MD2

 

1Chair, Department of Surgery, St. Elizabeth’s Medical Center, Boston, Massachusetts; Professor of Surgery, Tufts University School of Medicine; 2Chief Medical Officer, Cruzar Medsystems, Inc, San Carlos, California

Frank Pomposelli, Jr, MD1; Albert K. ...
It is estimated that CTO is present in up to 40% of patients with symptomatic PAD. Initial guidewire passage required to perform successful intervention on the atherosclerotic segment becomes more difficult with the occurrence of CTO.
It is estimated that CTO is present in up to 40% of patients with symptomatic PAD. Initial guidewire passage required to perform successful intervention on the atherosclerotic segment becomes more difficult with the occurrence of CTO.
It is estimated that CTO is...
07/16/2018
Vascular Disease Management
Case Report
Learn How Access Strategy Impacts Complex CTO Crossing
04/06/2018

Arthur C. Lee, MD

 

 

The Cardiac & Vascular Institute, Gainesville, Florida

Arthur C. Lee, MD     The Cardiac ...
Access strategy for chronic total occlusions (CTOs) is crucial in obtaining procedural success. Some access sites may have a higher complication rate or be more technically difficult to obtain; therefore, the pros and cons of the approach...
Access strategy for chronic total occlusions (CTOs) is crucial in obtaining procedural success. Some access sites may have a higher complication rate or be more technically difficult to obtain; therefore, the pros and cons of the approach...
Access strategy for chronic...
04/06/2018
Vascular Disease Management
Editor's Corner
How Can We Improve Outcomes in CLI and PAD?
03/26/2018

Craig Walker, MD

 

Cardiovascular Institute of the South, Houma, Louisiana

Craig Walker, MD   Cardiovascular I...
Dr. Walker comments on overall medical evaluation and medical therapy of patients presenting with CLI and PAD.
Dr. Walker comments on overall medical evaluation and medical therapy of patients presenting with CLI and PAD.
Dr. Walker comments on overall...
03/26/2018
Vascular Disease Management
Editor's Corner
Zilver PTX in Long Lesions: Try the Jacket On
02/09/2018

John A. Phillips, MD, FSCAI, RPVI

OhioHealth Heart and Vascular Physicians, Columbus, Ohio

John A. Phillips, MD, FSCAI, RPVI Oh...
The authors evaluated their 1- and 2-year patency rates as well as the clinically driven reintervention rates in their patients with diffuse de novo and instent restenotic FP atherosclerotic lesions greater than 20 cm who received the Zilver...
The authors evaluated their 1- and 2-year patency rates as well as the clinically driven reintervention rates in their patients with diffuse de novo and instent restenotic FP atherosclerotic lesions greater than 20 cm who received the Zilver...
The authors evaluated their 1-...
02/09/2018
Vascular Disease Management

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

Dermatology Week
November 13 ⁠–⁠ November 16
November 23 ⁠–⁠ November 24
December 4 ⁠–⁠ December 5
Great Debates & Updates in Diabetic Foot
December 6 ⁠–⁠ December 7
December 9 ⁠–⁠ December 11
AIBD
December 9 ⁠–⁠ December 11
Psych Congress Primary Care Online Series
December 12 ⁠–⁠ December 13
December 14 ⁠–⁠ December 15
February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use